Tomasz Szczepański
Biographic Data
| ID | 8252620 |
|---|---|
| NAME | Tomasz Szczepański |
| GIVEN NAMES | Tomasz |
| FAMILY NAME | Szczepański |
| SIGNATURE | SZCZEPAŃSKI T |
| AFFILIATIONS | Medical University of Silesia |
| ORCID | 0000-0001-5336-261X |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
The Outcomes of Myeloid Sarcoma in 64 Pediatric Patients and the Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Treatment Results
Background: Myeloid sarcoma (MS) is a malignant extramedullary tumor that occurs in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia (CML). The standard first-line treatment for MS is intensive chemotherapy according to the AML protocol, regardless of bone marrow involvement. The role of allogeneic hematopoietic stem cell transplantation (alloHSCT) in the treatment of pediatric patients with …
Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland
Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating significant clinical activity. Importantly, the in-terventions could be potentially molecularly guided as vulnerabilities to BH3-mimetics were re-ported. Currently venetoclax is not incorporated into paedi…
Recenzja
Publikacja z okazji nadania Pani Jolancie Wadowskiej-Król godności Doktora Honoris Causa Uniwersytetu Śląskiego w Katowicach
No prominent works on this page.
Recenzja
Publikacja z okazji nadania Pani Jolancie Wadowskiej-Król godności Doktora Honoris Causa Uniwersytetu Śląskiego w Katowicach
Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland
Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating significant clinical activity. Importantly, the in-terventions could be potentially molecularly guided as vulnerabilities to BH3-mimetics were re-ported. Currently venetoclax is not incorporated into paedi…
The Outcomes of Myeloid Sarcoma in 64 Pediatric Patients and the Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Treatment Results
Background: Myeloid sarcoma (MS) is a malignant extramedullary tumor that occurs in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia (CML). The standard first-line treatment for MS is intensive chemotherapy according to the AML protocol, regardless of bone marrow involvement. The role of allogeneic hematopoietic stem cell transplantation (alloHSCT) in the treatment of pediatric patients with …
Acute Myeloid Leukemia Research (2 works) · Leukemia (2 works) · Acute Lymphoblastic Leukemia research (1 work) · Cancer (1 work) · Chemotherapy (1 work) · Chronic Lymphocytic Leukemia Research (1 work) · Chronic Myeloid Leukemia Treatments (1 work) · Cohort (1 work) · Context (archaeology (1 work) · Family medicine (1 work)